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Objective: Congenital hypothyroidism (CH) refers to a condition in which there is a low level of 
thyroid hormone in an infant’s blood. It can result in serious problems in physical and mental 
development of patients. This study aimed to compare growth indices in patients with and without 
CH. 
Materials and Methods: Historical cohort study, 96 patients with CH in different counties of 
Kurdistan province were considered as exposed cases. The non-exposed group included children of 
the same age, sex and geographical area as much as possible. Independent t-test was used to compare 
growth indices in the two groups. Moreover, repeated measurement was used to compare the two 
groups in terms of trend of changes in growth.  
Results: There was a significant difference between the two groups of neonates in terms of weight 
and head circumference measured at third and ninth months of ages (p<0.05) respectively. Moreover, 
no statistically significant difference was observed between the two groups in terms of the trend of 
changes in growth percentiles (head circumference, height, and weight) (p>0.05). 
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Introduction 
Congenital hypothyroidism (CH) is one of the 
most common diseases of endocrine 
metabolism and one of the most frequent 
causes of treatable physical growth disorders 
and mental disability (1). Patients with 
congenital hypothyroidism have low levels of 
thyroid hormone in their blood; such a 
condition is due to defects in the structure of 
the thyroid gland, defects in biosynthesis of 
thyroid hormone, or malfunction of 
hypothalamus or Pituitary gland (2). 
Most neonate with CH are normal at birth, but 
in the event of late diagnosis and treatment, 
impaired physical and neurological 
development of the impulse, such as mental 
retardation (3, 4). Timely and effective 
treatment, achieving a good metabolic control, 
and maintaining these conditions during 
treatment can help to maintain normal 
intelligence quotient and ensure normal 
growth and development of the patient. 
Different studies have shown varies finding 
from the growth of neonate with CH. It seems 
that there are several factors, including starting 
time ,initial dose, disease severity ,affect to 
physical normality of neonate (4).The 
incidence of CH varies in different regions. 
The disease incidence has been reported 
1:800-3000 live births in the world (5-8), In 
Iran, several studies indicate different 
incidence of CH (9-11). In Kurdistan Province, 
a western province in Iran which is located in 
a mountainous region, the population is mainly 
from Kurd ethnicity and the prevalence of the 
disease is about one per 414 live births (12).  
Of the total patients 202 (22.6%) were 
permanent and The mean start of treatment 
was 21 days after birth (13). Another study 
evaluated the neurocognitive impairments in 
CH Patients have been done in Kurdistan 
province (14), therefore in this study; we 
decided to comparison the anthropometric 
indices of children with CH with healthy 
infants. 
 
Materials and Methods 
This study was a retrospective (historical) 
cohort study that was conducted in 2014 in 
Kurdistan province located in west of Iran. 
The study was approved by the ethics 
committee of Kurdistan University of Medical 
Sciences. After selecting the subjects, their 
parents were contacted and the objectives of 
the study were explained; then, the parents 
were asked to allow home visits. Before 
visiting homes of the subjects, their medical 
files were reviewed and the required data were 
recorded so that to find the deficiencies. 
A total of 96 children with congenital 
hypothyroidism aged more than 42 months, 
who were diagnosed in different counties of 
Kurdistan during the years 2005-2013, were 
considered as exposed group and enrolled into 
the study via census sampling method. 
Congenital hypothyroidism screening program 
was started in Iran in 2005. This program 
collects patient data from every county; the 
forms used in this program are the same all 
across the country and they are completed on a 
regular basis. In order to implement congenital 
hypothyroidism screening program, three to 
five days after birth a Lancet was used to 
collect a few drops of blood from the baby's 
heel. The blood drops were poured on a paper 
filter. After drying, which usually took three 
hours, using priority mail they were sent to 
neonatal screening laboratories in the capital 
city of the province. After conducting the tests, 
the cases with a TSH less than 5 mu/L were 
classified as healthy children and the other 
cases which were susceptible were invited for 
further tests. In patients with a THS between 5 
and 9.9, the second paper filter was obtained 
and those with a TSH more than 10 were 
referred to a focal point to undergo serum tests 
for confirmation or rejection of the disease. 
The ideal time for starting treatment is about 
two to three weeks after birth. The exposed 
infants were treated with a dose of 10 to 15 
µg/kg/day of levothyroxine. Monitoring of 
TSH and T4 was done every 1-2 month during 
the first year of life and every 1-3 month 
during the second and third year. After three 
years of treatment of the disease, the process 
of treatment was stopped for two to four weeks 
and the tests were repeated to determine 
whether the disease is transient or permanent. 
The cases with normal test results were 
classified as transient cases and the treatments 
for them was discontinued, otherwise the 
patient was classified as a permanent type and 
the patients had to continue the treatment until 
the end of their life (15). The non-exposed 
group included children of the same age and 
sex who were selected from the same 
geographical area as much as possible. The 
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were normal. The members of this group were 
selected using the list of vaccination registered 
in the studied health centers. 
Eligibility for including in this study were 
cases had CH diagnosed by a newborn 
screening program and confirmed by venous 
blood samples, and also if they had been 
treated with levothyroxine, and CH patients 
with concomitant disease or complications 
such as genetic disorders, IUGR, prematurity 
were excluded. 
Assessment tool: After selecting the subjects, 
their medical files were reviewed. 
Anthropometric data of the studied children 
were collected from their medical files, which 
had been already registered in the health 
centers. Supine length until the age of 2 years 
(before walking) and then standing height 
were measured without shoes by using a tape 
meter against a wall with a precision of 10mm. 
weight was measured with scale that was 
placed on a flat ground. Head circumference 
was measured using a non-elastic tape with a 
precision 0f 10 mm(16). The data on care 
services provided for the patients with 
congenital hypothyroidism were extracted 
either from files registered in physicians’ 
offices (if the patient received medical care 
form a specialist), from the medical files 
registered in the health centers (if the patient 
received medical care from physicians 
working in health centers), or from their 
treatment cards which were registered by their 
parents. 
The collected data were entered into SPSS 
version 20 software and mean and frequency 
of each item were calculated for each group. 
Independent t-test was used to compare growth 
indices in the two groups. In addition, 
Repeated Measurement test was used to 
compare the two groups in terms of the trend 
of growth. Chi-square test and Fisher's test 




Our study was conducted on a total of 192 
persons, of whom 96 persons had congenital 
hypothyroidism and the other 96 persons were 
normal. Of all, 118 subjects (62%) were male 
and half of them (59 persons) had congenital 
hypothyroidism; moreover, 74 persons (38%) 
were female and half of them (37 persons) had 
congenital hypothyroidism. Of all, 72.6% were 
living in urban areas and 27.4% in rural areas. 
Based on the results, 97.8% of infants with 
congenital hypothyroidism and 100% of 
normal infants were breast-fed. The mean 
(SD) age of mothers at the time of delivery 
was 28.3 ± 5.4 years in those whose neonates 
had hypothyroidism and 29 ± 6.8 years in 
those with normal neonates. 
There was no statistically significant 
difference between the two groups in terms of 
the number of children (p=0.533), mother’s 
education (p=0.552), father's education 
(p=0.157), father’s job (p=0.199), location of 
residence (p=1.000), type of milk used for 
feeding the child (p=0.497), mean age of 
mother at the time of childbirth (p=0.410).  
As shown in Table 1, there was a statistically 
significant difference between the two groups 
in terms of the mean head circumference at 
ninth months of age (p=0.008).  
 
The results of repeated measurement analysis 
showed no significant difference between the 
two groups in terms of the trend of changes in 
head circumference growth percentile. There 
was no statistically significant difference 
between the two groups in terms of the mean 
height of children from birth to 36th months of 
age (p>0.05). The results of Repeated 
Measurement analysis showed no significant 
difference between the two groups in terms of 
the trend of changes in height growth 
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significant difference between the two groups 
in terms of the mean weight of children at 
third months of age (p=0.002). The results of 
Repeated Measurement analysis showed no 
significant difference between the two groups 




This study used anthropometric indicators to 
evaluate the growth of children with 
congenital hypothyroidism; the patients had 
been already detected by a screening program 
and were under treatment. Based on the 
findings of this study, growth parameters in 
children with congenital hypothyroidism were 
different from those in the control group 
however with increasing the age of children in 
both groups, height, weight, and head 
circumference of patients got closer to those of 
normal children and the differences became 
trivial. In other words, timely and appropriate 
treatment of children with congenital 
hypothyroidism may help to grow up children 
with almost normal height, weight, and head 
circumference. In this study, there was a 
significant difference between the two groups 
in terms of mean head circumference of the 
subjects nine month after birth. Moreover, 
there was a difference between the two groups 
in terms of the mean weight of the subjects 
three months after birth however there was no 
difference between the two groups in terms of 
the mean height. 
 In a study conducted in Spain, there was no 
significant difference between patients with 
congenital hypothyroidism and normal group 
in terms of height and body mass index (BMI). 
However, three months after birth, there was a 
statistically significant difference between the 
two groups of children in terms of weight (p 
<0.02) which is in line with the results of our 
study (17). On the other hand, in a study by 
Siragusa, head circumference of people who 
had been affected by neonatal congenital 
hypothyroidism was significantly more than 
that of the normal subjects(18). In Bucher’s 
study it was found that one to three months 
after birth head circumference of children 
under levothyroxine treatment become similar 
to that of the normal subjects; moreover, with 
increasing age and continuing the course of 
treatment, patients’ head circumference was 
significantly increased (19). 
In a study conducted in France, height, weight, 
head circumference, and BMI of the subjects 
were measured and it was found that the mean 
height of children aged one and two years with 
severe congenital hypothyroidism was lower 
than the normal range; it might be attributed to 
the physical factors related to the height 
measurement and estimation methods (20). 
However, at the ages of three to four years, 
mean height of patients was normal that is 
consistent with our results. 
In our study, Repeated Measurement analysis 
was used to compare the trends of changes in 
growth percentiles of head circumference, 
height, and weight; according to the results, no 
significant difference was observed between 
the two groups (Figure 1, 2, 3). However, in a 
study by Faizi et al., there were statistically 
significant differences between children with 
congenital hypothyroidism and normal 
subjects in terms of growth percentiles of 
weight, height, and head circumference 
(p<0.001)(4).  
The results showed that timely diagnosis and 
appropriate treatment of newborns with 
congenital hypothyroidism led to 
improvements in growth percentiles (head 
circumference, height, weight) from birth up to 
36th month of age. Although some differences 
were observed at different time intervals, 
appropriate care services and treatment 
interventions were effective in reducing the 
differences between the two groups in terms of 
growth percentiles. 
In order to further investigate the factors that 
contribute to differences in growth indices in 
children with congenital hypothyroidism (as 
compared with the normal population), it is 
suggested to carry out a prospective cohort 
study or conduct a nested case-control study to 
investigate multiple factors affecting 
congenital hypothyroidism. Low awareness of 
the families, health and medical personnel, and 
physicians can lead to delays in timely 
diagnosis and appropriate treatment of 
newborns with the disease; it can have 
irreversible effects on individuals, families, 
and the community. In order to appropriately 
manage treatment services it is necessary to 
make proper plans, involve families in the 
programs to pay more attention to the disease, 
and promote physicians’ awareness about 
suitable disease control methods. In addition, 





This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 3.0 (CC BY-NC 3.0). 
RBMS.	2020;25(1):e14	
of growth indices in normal infants and 
children with the disease can help to decrease 
the differences between normal population and 
the patients in terms of growth indices. 
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